Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk

Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Carcinogenesis (New York) Ročník 31; číslo 10; s. 1748
Hlavní autori:	Tindall, E A, Severi, G, Hoang, H N, Ma, C S, Fernandez, P, Southey, M C, English, D R, Hopper, J L, Heyns, C F, Tangye, S G, Giles, G G, Hayes, V M
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.10.2010
Predmet:	Chromosomes, Human, Pair 5 Genetic Predisposition to Disease Genotype Haplotypes Humans Interleukin-4 - blood Interleukin-4 - genetics Male Polymorphism, Single Nucleotide Promoter Regions, Genetic Prostatic Neoplasms - genetics RNA, Messenger - analysis
ISSN:	1460-2180, 1460-2180
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in prostate cancer risk. Per allele odds ratios (ORs) are 1.32 [95% confidence interval (CI) 1.08-1.61, P = 0.006] and 1.26 (95% CI 1.07-1.48, P = 0.005), respectively. Although these associations were not replicated in an analysis of the Melbourne Collaborative Cohort Study, including 810 cases and 1733 controls, no clinicopathological characteristic was implicated for this divergence. Correlating rs2243250 genotypes to IL-4 gene transcript levels and circulating IL-4 plasma levels, we observe in contrast to previous reports, a non-significant trend toward the minor T-allele decreasing the likelihood of IL-4 activity. From our observed association between a low IL-4 producing promoter T-allele and prostate cancer risk, our study suggests an antitumor role for IL-4 in prostate cancer. Although we saw no association for IL-5 or IL-13 gene variants and prostate cancer risk, our findings call for further evaluation of IL-4 as a contributor to prostate cancer susceptibility.
AbstractList	Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in prostate cancer risk. Per allele odds ratios (ORs) are 1.32 [95% confidence interval (CI) 1.08-1.61, P = 0.006] and 1.26 (95% CI 1.07-1.48, P = 0.005), respectively. Although these associations were not replicated in an analysis of the Melbourne Collaborative Cohort Study, including 810 cases and 1733 controls, no clinicopathological characteristic was implicated for this divergence. Correlating rs2243250 genotypes to IL-4 gene transcript levels and circulating IL-4 plasma levels, we observe in contrast to previous reports, a non-significant trend toward the minor T-allele decreasing the likelihood of IL-4 activity. From our observed association between a low IL-4 producing promoter T-allele and prostate cancer risk, our study suggests an antitumor role for IL-4 in prostate cancer. Although we saw no association for IL-5 or IL-13 gene variants and prostate cancer risk, our findings call for further evaluation of IL-4 as a contributor to prostate cancer susceptibility. Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in prostate cancer risk. Per allele odds ratios (ORs) are 1.32 [95% confidence interval (CI) 1.08-1.61, P = 0.006] and 1.26 (95% CI 1.07-1.48, P = 0.005), respectively. Although these associations were not replicated in an analysis of the Melbourne Collaborative Cohort Study, including 810 cases and 1733 controls, no clinicopathological characteristic was implicated for this divergence. Correlating rs2243250 genotypes to IL-4 gene transcript levels and circulating IL-4 plasma levels, we observe in contrast to previous reports, a non-significant trend toward the minor T-allele decreasing the likelihood of IL-4 activity. From our observed association between a low IL-4 producing promoter T-allele and prostate cancer risk, our study suggests an antitumor role for IL-4 in prostate cancer. Although we saw no association for IL-5 or IL-13 gene variants and prostate cancer risk, our findings call for further evaluation of IL-4 as a contributor to prostate cancer susceptibility.Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in prostate cancer risk. Per allele odds ratios (ORs) are 1.32 [95% confidence interval (CI) 1.08-1.61, P = 0.006] and 1.26 (95% CI 1.07-1.48, P = 0.005), respectively. Although these associations were not replicated in an analysis of the Melbourne Collaborative Cohort Study, including 810 cases and 1733 controls, no clinicopathological characteristic was implicated for this divergence. Correlating rs2243250 genotypes to IL-4 gene transcript levels and circulating IL-4 plasma levels, we observe in contrast to previous reports, a non-significant trend toward the minor T-allele decreasing the likelihood of IL-4 activity. From our observed association between a low IL-4 producing promoter T-allele and prostate cancer risk, our study suggests an antitumor role for IL-4 in prostate cancer. Although we saw no association for IL-5 or IL-13 gene variants and prostate cancer risk, our findings call for further evaluation of IL-4 as a contributor to prostate cancer susceptibility.
Author	Southey, M C Tangye, S G Hayes, V M Hopper, J L Tindall, E A Heyns, C F Severi, G Hoang, H N Fernandez, P Ma, C S English, D R Giles, G G
Author_xml	– sequence: 1 givenname: E A surname: Tindall fullname: Tindall, E A organization: Cancer Genetics Group, Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, Randwick, NSW 2031, Australia – sequence: 2 givenname: G surname: Severi fullname: Severi, G – sequence: 3 givenname: H N surname: Hoang fullname: Hoang, H N – sequence: 4 givenname: C S surname: Ma fullname: Ma, C S – sequence: 5 givenname: P surname: Fernandez fullname: Fernandez, P – sequence: 6 givenname: M C surname: Southey fullname: Southey, M C – sequence: 7 givenname: D R surname: English fullname: English, D R – sequence: 8 givenname: J L surname: Hopper fullname: Hopper, J L – sequence: 9 givenname: C F surname: Heyns fullname: Heyns, C F – sequence: 10 givenname: S G surname: Tangye fullname: Tangye, S G – sequence: 11 givenname: G G surname: Giles fullname: Giles, G G – sequence: 12 givenname: V M surname: Hayes fullname: Hayes, V M
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/20403914$$D View this record in MEDLINE/PubMed
BookMark	eNpNkD1rwzAYhEVJaT7asWvR1smJZCuyPJbQj0CgSzub1_JrW40tJZIdyNw_XkNT6HQH93AcNycT6ywScs_ZkrMsWWnw2thVUR-Z4ldkxoVkUcwVm_zzUzIP4YsxLpN1dkOmMRMsybiYke-N6w4eG7TBnJCChfYcTKCuon2DVJ97tzcWI290Q3XjXeeC65CujwlfcuqxNs7SMNQ1hj5QoN61SCvn6XYXCVqjRXoCb8COqbH04F3ooR-bwWr01JuwvyXXFbQB7y66IJ8vzx-bt2j3_rrdPO0iLbK0jyqZxFpyFRdQsUxoBKFKKWQWq4JlKICriknkWkooJTCBslQcSrXWVcw5xgvy-Ns7jjgO4968M0Fj24JFN4Q8Xac8VUmqRvLhQg5Fh2V-8KYDf87_fot_AL7xc1o
CitedBy_id	crossref_primary_10_1155_2022_1259009 crossref_primary_10_1007_s00580_017_2521_4 crossref_primary_10_1007_s12072_016_9721_x crossref_primary_10_1007_s12020_020_02486_z crossref_primary_10_1016_j_micpath_2021_104959 crossref_primary_10_1186_1471_2369_13_2 crossref_primary_10_1002_jcp_24237 crossref_primary_10_1038_cgt_2013_77 crossref_primary_10_1111_j_1365_2559_2011_04033_x crossref_primary_10_1002_jcb_25853 crossref_primary_10_1186_s12885_022_09633_x crossref_primary_10_1371_journal_pone_0079187 crossref_primary_10_1016_j_molimm_2012_10_039 crossref_primary_10_1177_1010428317701442 crossref_primary_10_2217_pgs_13_240 crossref_primary_10_1111_iji_12098 crossref_primary_10_1016_j_humimm_2011_08_003 crossref_primary_10_1097_CEJ_0000000000000503 crossref_primary_10_1111_sji_12136 crossref_primary_10_3390_cancers3044281 crossref_primary_10_1016_j_jpge_2015_04_001 crossref_primary_10_1186_1897_4287_11_19 crossref_primary_10_1038_s41598_025_06882_1 crossref_primary_10_3892_etm_2012_454 crossref_primary_10_1016_j_gene_2016_04_050 crossref_primary_10_3109_10408363_2014_906130 crossref_primary_10_1371_journal_pone_0252220 crossref_primary_10_1007_s13277_015_3593_x crossref_primary_10_1007_s13277_013_0761_8
ContentType	Journal Article
CorporateAuthor	Australian Prostate Cancer BioResource
CorporateAuthor_xml	– name: Australian Prostate Cancer BioResource
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1093/carcin/bgq081
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1460-2180
ExternalDocumentID	20403914
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29B 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABDFA ABEFU ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABMNT ABNGD ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABVGC ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHMMS AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CGR COF CS3 CUY CVF CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS ECM EE~ EIF EIHJH EJD ELUNK EMOBN F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RHF RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H X7M XOL YAYTL YKOAZ YXANX ZGI ZKB ZKX ZXP ~91 7X8 ABPQP ABXZS ADNBA AGQPQ AJBYB AJNCP ALXQX ESTFP JXSIZ
ID	FETCH-LOGICAL-c497t-f632c6182baf094cea48d646928b09e4a18f06e1c66ad6a04e6d81ad85cf211e2
IEDL.DBID	7X8
ISICitedReferencesCount	33
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000282750100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1460-2180
IngestDate	Sat Sep 27 23:45:17 EDT 2025 Wed Feb 19 01:52:54 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c497t-f632c6182baf094cea48d646928b09e4a18f06e1c66ad6a04e6d81ad85cf211e2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://academic.oup.com/carcin/article-pdf/31/10/1748/7517208/bgq081.pdf
PMID	20403914
PQID	757178378
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_757178378 pubmed_primary_20403914
PublicationCentury	2000
PublicationDate	2010-10-01
PublicationDateYYYYMMDD	2010-10-01
PublicationDate_xml	– month: 10 year: 2010 text: 2010-10-01 day: 01
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	Carcinogenesis (New York)
PublicationTitleAlternate	Carcinogenesis
PublicationYear	2010
SSID	ssj0016359
Score	2.1686585
Snippet	Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1748
SubjectTerms	Chromosomes, Human, Pair 5 Genetic Predisposition to Disease Genotype Haplotypes Humans Interleukin-4 - blood Interleukin-4 - genetics Male Polymorphism, Single Nucleotide Promoter Regions, Genetic Prostatic Neoplasms - genetics RNA, Messenger - analysis
Title	Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk
URI	https://www.ncbi.nlm.nih.gov/pubmed/20403914 https://www.proquest.com/docview/757178378
Volume	31
WOSCitedRecordID	wos000282750100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-_3QDaymeTiOMyGEQCBBxQBSt8qxzxQhkrYplZj545yTABNiYMmUSJZ9Pn9f7vN9jJ3kKjORzBOOziAXYY48i23Kc5dHWmZpYk1jNpH2eqrfz-5bbU7Vyiq_cmKdqG1p_D_ybpoQ8fDdz89GY-5No3xxtXXQmGedmJCMV3Sl_Z8iAp2lWXO5KOB0kgVti03i8F3jjXqKbv40DlT4O7isD5mr1X8Ob42ttOgSzptwWGdzWGywpbu2fr7JPvz2n-CwUa2DbjuSQOmAgCCY92n5Qi9ySo5DMEMv1avKV4RkHIenIXgXh7KA6u3JV6Uq0ODFiUC4F25uuQAKRoQZsW8vroHnAkb-TgmhWTA-uCbghexb7PHq8uHimrc2DNyILJ1yJ-PISOIhuXZEBg1qoawkWh2pPMhQ6FC5QGJopNRW6kCgtCrUViXGEb3EaJstFGWBuwwUukQH1ohUoJCOwKO2hgArLZVFq5M9Bl-zO6Aw97ULXWD5Vg2-53eP7TQrNBg17TgGEeWhOAvF_t8fH7Dluvpfi_EOWcfRFscjtmhm0-dqclyHDz1793ef6VHTLQ
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+analysis+of+the+cytokine-rich+chromosome+5q31.1+region+suggests+a+role+for+IL-4+gene+variants+in+prostate+cancer+risk&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Tindall%2C+E+A&rft.au=Severi%2C+G&rft.au=Hoang%2C+H+N&rft.au=Ma%2C+C+S&rft.date=2010-10-01&rft.issn=1460-2180&rft.eissn=1460-2180&rft.volume=31&rft.issue=10&rft.spage=1748&rft_id=info:doi/10.1093%2Fcarcin%2Fbgq081&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2180&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2180&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2180&client=summon